Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Operating Leases (2019 - 2025)

Jaguar Health (JAGX) has disclosed Operating Leases for 6 consecutive years, with $918000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases rose 21.75% to $918000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $918000.0, a 21.75% increase, with the full-year FY2024 number at $686000.0, down 22.57% from a year prior.
  • Operating Leases was $918000.0 for Q3 2025 at Jaguar Health, down from $960000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $998000.0 in Q1 2025 to a low of $351000.0 in Q3 2023.
  • A 5-year average of $792444.4 and a median of $847000.0 in 2021 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: crashed 52.44% in 2023, then soared 114.81% in 2024.
  • Jaguar Health's Operating Leases stood at $919000.0 in 2021, then dropped by 21.11% to $725000.0 in 2022, then grew by 22.21% to $886000.0 in 2023, then decreased by 22.57% to $686000.0 in 2024, then skyrocketed by 33.82% to $918000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Operating Leases are $918000.0 (Q3 2025), $960000.0 (Q2 2025), and $998000.0 (Q1 2025).